Please change the country on your profile in order to switch to another country store.
Enterprise Solutions for cell and gene therapy
Removing barriers to delivering life-saving therapies
Overcoming obstacles
To meet current and future demands for cell and gene therapies, production must be efficient, cost-effective, and scalable. Knock down the barriers that block your progress towards these goals with the support of Cytiva's process development and manufacturing services, integrated platforms, and staff training.
Automating and functionally closing the workflow improves efficiency while protecting the quality of cellular products. A modular approach offers the flexibility to remove bottlenecks or optimize individual steps. Let us help you refine your process using innovative technologies that you can then bring to your site.
Viral vectors of appropriate quality are in short supply, putting clinical timelines at risk. Bringing adeno-associated virus (AAV) and lentivirus (LV) vector production in-house is one way to mitigate this risk. GE can help you develop and implement an end-to-end solution that puts you in control.
An ever-changing market drives the need for flexible manufacturing. But scalability, efficiency, and reducing risk are important, too. To help you deal with the complexity, we offer a variety of customizable solutions.
